Condition: Diminished Ovarian Reserve · Sponsor: Generation Next Fertility
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
This description comes directly from the study's public registry record.
Alicia Broussard, PhD · 3174456958 · a.broussard@generationnextfertility.com
Jesse Hade, MD · 2126410906 · j.hade@generationnextfertility.com
Always discuss trial participation with your own doctor first.
| Generation Next Fertility | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05790655